WV
Wave Life Sciences Ltd.
WVE · NASDAQ
$4.44 -3.16% (-$0.14)
1M -18.08%
Market Cap $874.9M
P/E Ratio -
Div. Yield -
ROE 50.12%
Piotroski F-Score Weak
3/9Valuation
45 /100
Fair P/B 1.93x
P/S 13.38x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 127.08%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 309.73%
Op. margin 333.36%
FCF margin 284.90%
Quality
2 /100
Poor ROE 50.12%
ROA 36.26%
Asset turnover 0.12x
Debt
100 /100
Low Current ratio 9.99x
Debt/Equity 0.10x
Net debt/EBITDA N/A
Stability
15 /100
Unstable Rev. volatility 1,753.97%
EPS volatility 75.28%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o WVE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Bolno
Employees
317
Headquarters
Cambridge
Nadchodzące wydarzenia
09 LIS
Earnings
Upcoming earnings report